Eberconazole

Eberconazole
Clinical data
Trade namesEbernet
Legal status
Legal status
  • US: Not FDA approved
Identifiers
  • 1-(1,3-Dichloro-6,11-dihydro-5H-dibenzo[1,2-a:1',4'-e] [7]annulen-11-yl)imidazole
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H14Cl2N2
Molar mass329.22 g·mol−1
3D model (JSmol)
  • C1CC2=CC(=CC(=C2C(C3=CC=CC=C31)N4C=CN=C4)Cl)Cl
  • InChI=1S/C18H14Cl2N2/c19-14-9-13-6-5-12-3-1-2-4-15(12)18(17(13)16(20)10-14)22-8-7-21-11-22/h1-4,7-11,18H,5-6H2
  • Key:MPTJIDOGFUQSQH-UHFFFAOYSA-N

Eberconazole is an antifungal drug. As a 1% topical cream, it is an effective treatment for dermatophytosis, candidiasis, and pityriasis.

It was approved for use in Spain in 2015 and is sold under the trade name Ebernet. It is also approved for use in Panama, Guatemala, Costa Rica, Honduras, and the Dominican Republic.